| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 150, Issue 7 2675-2686, Copyright © 1993 by American Association of Immunologists
ARTICLES |
D Lopez, DF Barber, JA Villadangos and JA Lopez de Castro
Centro de Biologia Molecular, Universidad Autonoma de Madrid, Spain.
HLA-B27- responder cells were stimulated in vitro with B*2705+ lymphoblastoid cell lines and alloreactive CTL clones were obtained by limiting dilution. Of the CD3+ CD4-CD8+ HLA-B27-specific CTL clones obtained, two of them, possessing the same TCR, cross-reacted with HLA- DR2. The fine specificity of these CTL was established with HLA-B27 and HLA-DR2 subtypes. They recognized the B*2701 to B*2706 subtypes, but only DR2Dw2. Lysis of DR2+ target cells was specifically inhibited by anti-CD3, anti-class II, and anti-DR mAb, but not with an anti-CD8 antibody. The monoclonal nature of the cross-reaction was established by the mutual inhibition of HLA-B27 and DR2Dw2 cells in cold target competition experiments. The DR2 protein involved in the cross-reaction was the heterodimer carrying the B5*0101 product, as shown by using L cell transfectants expressing each of the two molecules encoded in the DR2Dw2 haplotype. A correlation between the fine specificity of these CTL clones and the amino acid sequences of HLA-B27 and HLA-DR2 subtypes revealed a shared structural motif between HLA-B27 and the DR2 B5*0101 chain, which could be related to the observed cross-reaction. This motif was contributed for by several residues located in adjacent beta strands, at the floor of the peptide-binding site. The contribution of two of these residues, as well as other beta-pleated sheet residues to HLA-B27 allorecognition by the cross-reactive CTL clones was directly demonstrated with site-directed mutants. These results suggest that the dual reactivity pattern reflects presentation of identical or structurally related peptide by HLA-B27 and HLA-DR2Dw2. As T cell cross- reactivity between HLA-B27 and HLA-DR2 was previously found in cells from an unrelated individual the results reported here are likely to reflect an intrinsic property of HLA-B27, rather than the fortuitous finding of a rare clonal reaction pattern. We speculate on the potential implications of these results for the pathogeny of HLA-B27- associated spondyloarthropathies.
This article has been cited by other articles:
|
|
 |
|
  L. H. Boyle and J. S. Hill Gaston Breaking the rules: the unconventional recognition of HLA-B27 by CD4+ T lymphocytes as an insight into the pathogenesis of the spondyloarthropathies Rheumatology, March 1, 2003; 42(3): 404 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ueno, H. Tomiyama, and M. Takiguchi Single T Cell Receptor-Mediated Recognition of an Identical HIV-Derived Peptide Presented by Multiple HLA Class I Molecules J. Immunol., November 1, 2002; 169(9): 4961 - 4969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. M. Heemskerk, R. A. de Paus, E. G. A. Lurvink, F. Koning, A. Mulder, R. Willemze, J. J. van Rood, and J. H. F. Falkenburg Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex PNAS, May 24, 2001; (2001) 111162298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. M. Heemskerk, R. A. de Paus, E. G. A. Lurvink, F. Koning, A. Mulder, R. Willemze, J. J. van Rood, and J. H. F. Falkenburg Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex PNAS, June 5, 2001; 98(12): 6806 - 6811. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
